Inventor
Laura Saunders
Inventor
San Francisco, CA, US
Overview
Patents· 38 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides21%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
C07DHeterocyclic compounds16%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
C12YEnzymes1%
PatentTitleYear
10,934,359Anti-BMPR1B antibodies and methods of use202110,533,051Anti SEZ6 antibodies and methods of use202010,428,156Anti-MFI2 antibodies and methods of use201910,308,721Anti-DLL3 antibodies and drug conjugates for use in melanoma201910,189,910Anti-DPEP3 antibodies and methods of use201910,137,204Anti-DLL3 antibody drug conjugates for treating cancer201810,053,511Anti-claudin antibodies and methods of use20189,993,566SEZ6 modulators and methods of use20189,937,268Anti-DLL3 antibody drug conjugates and methods of use20189,931,421Methods of delivering DLL3 antibody drug conjugates20189,931,420Methods of making DLL3 antibody drug conjugates20189,878,053'Methods of delivering DLL3 antibody drug conjugates'20189,867,887'Anti-DLL3 antibody drug conjugates'20189,861,708'Kits containing DLL3 antibody drug conjugates'20189,855,343'Anti-DLL3 antibody drug conjugates'20189,775,916'Anti-DLL3 antibody drug conjugates for treating cancer'20179,777,071'Anti-DPEP3 antibodies and methods of use'20179,770,518'Anti-DLL3 antibody drug conjugates'20179,764,042'Methods of making DLL3 antibody drug conjugates'20179,676,850'Anti SEZ6 antibodies and methods of use'20179,486,537'Anti-DLL3 antibody drug conjugates'20169,481,727'Anti-DLL3 antibody drug conjugates'20169,480,757'Anti-DLL3 antibody drug conjugates'20169,358,304'Methods of making DLL3 antibody drug conjugates'20169,353,182'Anti-DLL3 antibodies'20169,352,051'Kits containing DLL3 antibody drug conjugates'20169,345,784'Methods of delivering DLL3 antibody drug conjugates'20169,334,318'Multivalent DLL3 antibodies'20169,173,959'Anti-DLL3 antibody drug conjugates'20159,155,803'Anti-DLL3 antibody drug conjugates and methods of use'20159,133,271'Anti-DLL3 antibody drug conjugates and methods of use'20159,107,961'Anti-DLL3 antibody drug conjugates for treating cancer'20159,089,615'Anti-DLL3 antibodies'20159,089,617'Anti-DLL3 antibody drug conjugates'20159,090,683'Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies'20159,089,616'Anti-DLL3 antibody drug conjugates and methods of use'20159,011,854'Anti-DLL3 antibody drug conjugates and methods of use'20158,986,972'Nucleic acid encoding DLL3 antibodies'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2016Patents assigned to STEMCENTRX INC (16)· patent assignee history
2015–2017Patents assigned to STEM CENTRX INC (7)· patent assignee history
2015–2021Based in San Francisco, CA, US· patent location history
2016–2021Patents assigned to ABBVIE STEMCENTRX LLC (23)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE STEMCENTRX LLC | 23 | 2016–2021 |
| STEMCENTRX INC | 16 | 2015–2016 |
| STEM CENTRX INC | 7 | 2015–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 38 | 2015–2021 |